Lv3
305 积分 2021-11-06 加入
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial
2天前
已完结
Dynamic responses of cancer-associated fibroblasts to therapy in primary liver cancer
4天前
求助中
Hepatocellular Carcinoma Immune Microenvironment Analysis: A Comprehensive Assessment with Computational and Classical Pathology
4天前
已完结
Hepatocellular Carcinoma Immune Microenvironment Analysis: A Comprehensive Assessment with Computational and Classical Pathology
4天前
已完结
Hepatocellular Carcinoma Immune Microenvironment Analysis: A Comprehensive Assessment with Computational and Classical Pathology
4天前
已完结
Immune-mediated multisystem injury associated with monoclonal gammopathy of clinical significance: a case report
9天前
已完结
Elements of cancer immunity and the cancer–immune set point
10天前
已完结
Metastatic Fibrolamellar Hepatocellular Carcinoma in a Young Adult: A Case Report and Narrative Review
22天前
已完结
Chemoradiotherapy With or Without Simultaneous Integrated Boost for Cervical Cancer With Full-Thickness Stromal Invasion
1个月前
已完结
Melanoma Clonal Heterogeneity Leads to Secondary Resistance after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes
1个月前
已完结
皖公网安备34019202002308
